Empowering the GM1 and GM2 community with a co-created education resource about a natural history study

被引：0
|
作者：
Lewi, Daniel [1 ]
Pangonis, Diana [2 ]
Stokes, Louis [3 ]
Cognitant, Alex M. [4 ]
Linthorst, Gisela [5 ]
机构：
[1] Cure & Act Tay Sachs CATS Fdn, London, England
[2] NTSAD, Brighton, MA USA
[3] Cognitant Grp Ltd, Oxford, England
[4] Cognitant, Partnerships, Abingdon, Oxon, England
[5] Azafaros, Naarden, Netherlands
来源：
MOLECULAR GENETICS AND METABOLISM | 2023年 / 138卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2022.107204
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
221
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [41] In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses
    Moeko Kohyama
    Akira Yabuki
    Kenji Ochiai
    Yuya Nakamoto
    Kazuyuki Uchida
    Daisuke Hasegawa
    Kimimasa Takahashi
    Hiroaki Kawaguchi
    Masaya Tsuboi
    Osamu Yamato
    BMC Veterinary Research, 12
  • [42] DETERMINATION BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF CEREBROSPINAL-FLUID GANGLIOSIDES IN GM1 AND GM2 GANGLIOSIDOSES
    KAYE, EM
    KOLODNY, EH
    ULLMAN, MD
    ANNALS OF NEUROLOGY, 1987, 22 (03) : 444 - 444
  • [43] HYDROLYSIS OF ALL GANGLIOSIDES, INCLUDING GM1 AND GM2, ON THIN-LAYER PLATES BY VIBRIO-CHOLERAE NEURAMINIDASE
    PORTOUKALIAN, J
    BOUCHON, B
    JOURNAL OF CHROMATOGRAPHY, 1986, 380 (02): : 386 - 392
  • [44] ACTION OF CLOSTRIDIUM-PERFRINGENS NEURAMINIDASE ON GANGLIOSIDES GM1 AND GM2 ABOVE AND BELOW CRITICAL MICELLE CONCENTRATION OF SUBSTRATE
    RAUVALA, H
    FEBS LETTERS, 1976, 65 (02) : 229 - 233
  • [45] In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses
    Kohyama, Moeko
    Yabuki, Akira
    Ochiai, Kenji
    Nakamoto, Yuya
    Uchida, Kazuyuki
    Hasegawa, Daisuke
    Takahashi, Kimimasa
    Kawaguchi, Hiroaki
    Tsuboi, Masaya
    Yamato, Osamu
    BMC VETERINARY RESEARCH, 2016, 12
  • [46] Humanistic burden of neurodegenerative lysosomal disorders in the US: insights from caregivers of patients living with GM1 and GM2 gangliosidoses
    Rodriguez, M.
    Heuer, K.
    Waggoner, C.
    Jussila, D.
    Perez, N.
    Krupnick, R.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S186 - S186
  • [47] Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli
    Antoine, T
    Priem, B
    Heyraud, A
    Greffe, L
    Gilbert, M
    Wakarchuk, BW
    Lam, JS
    Samain, E
    CHEMBIOCHEM, 2003, 4 (05) : 406 - 412
  • [48] Prospective longitudinal study of neurological disease trajectory in children living with late-infantile or juvenile onset of GM1 or GM2 gangliosidosis (PRONTO study)
    Giugliani, Roberto
    Heron, Benedicte
    Jarnes, Jeanine R.
    Patterson, Marc C.
    Scarpa, Maurizio
    Doppler, Emilie
    Luzy, Cecile Paquet
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S47 - S48
  • [49] Empowering the GM2 gangliosidosis community: Developing a single clinical toolkit for clinicians, patients and caregivers in the UK
    Lewi, Daniel
    Durao, Patricia
    Stokes, Louis
    MacKillop, Iona
    Wiltshire, Matthew
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [50] PRECURSOR PRODUCT RELATIONSHIP BETWEEN GM1 AND GD1A BIOSYNTHESIZED FROM EXOGENOUS GM2 GANGLIOSIDE IN RAT-LIVER
    TRINCHERA, M
    GHIDONI, R
    JOURNAL OF BIOCHEMISTRY, 1990, 107 (04): : 619 - 623
12345